{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:38:34Z","timestamp":1787017114206,"version":"build-2736575974"},"reference-count":9,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.s455","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:20:13Z","timestamp":1773066013000},"page":"s455","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Vinay Prasad leaves FDA again amid dispute over Huntington\u2019s disease treatment"],"prefix":"10.1136","volume":"392","author":[{"given":"Mun Keat","family":"Looi","sequence":"first","affiliation":[{"name":"The BMJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026030911200737000_392.mar09_3.s455.1","unstructured":"Perrone M. Trump administration\u2019s embattled FDA vaccine chief is leaving for the second time. AP. 6 Mar 2026. https:\/\/apnews.com\/article\/vinay-prasad-fda-trump-vaccine-moderna-fired-bf56fe9852def8c9f1b9a648e5bb92df"},{"key":"2026030911200737000_392.mar09_3.s455.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r1611"},{"key":"2026030911200737000_392.mar09_3.s455.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r1723"},{"key":"2026030911200737000_392.mar09_3.s455.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.s287"},{"key":"2026030911200737000_392.mar09_3.s455.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.s339"},{"key":"2026030911200737000_392.mar09_3.s455.6","unstructured":"Phase 1\/2 clinical trial of AMT-130. UniQure. https:\/\/www.uniqure.com\/programs-pipeline\/phase-1-2-clinical-trial-of-amt-130"},{"key":"2026030911200737000_392.mar09_3.s455.7","unstructured":"UniQure provides regulatory update on AMT-130 for Huntington\u2019s disease. UniQure. 2 Mar 2026. https:\/\/uniqure.gcs-web.com\/node\/12511\/pdf"},{"key":"2026030911200737000_392.mar09_3.s455.8","unstructured":"Liu A, Incorvaia D. Senior FDA official refutes UniQure claims amid controversy over Huntington\u2019s gene therapy. Fierce Biotech. 5 Mar 2026. https:\/\/www.fiercebiotech.com\/biotech\/senior-fda-official-refutes-uniqure-claims-amid-controversy-over-huntingtons-gene-therapy"},{"key":"2026030911200737000_392.mar09_3.s455.9","unstructured":"Smith G, Langreth R. FDA push for fake brain surgery trial spurs ethical concerns. 4 Mar 2026. Bloomberg. https:\/\/www.bloomberg.com\/news\/articles\/2026-03-04\/fda-push-for-10-hour-fake-brain-surgery-trial-raises-ethical-concerns"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.s455","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.s455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:20:14Z","timestamp":1773080414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.s455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":9,"alternative-id":["10.1136\/bmj.s455"],"URL":"https:\/\/doi.org\/10.1136\/bmj.s455","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}